Cargando…

Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine

Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Takayasu, Fujioka, Shinsuke, Kawazoe, Miki, Inoue, Kotoe, Arima, Hisatomi, Tsuboi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146870/
https://www.ncbi.nlm.nih.gov/pubmed/35629260
http://dx.doi.org/10.3390/jpm12050838
_version_ 1784716668756295680
author Mishima, Takayasu
Fujioka, Shinsuke
Kawazoe, Miki
Inoue, Kotoe
Arima, Hisatomi
Tsuboi, Yoshio
author_facet Mishima, Takayasu
Fujioka, Shinsuke
Kawazoe, Miki
Inoue, Kotoe
Arima, Hisatomi
Tsuboi, Yoshio
author_sort Mishima, Takayasu
collection PubMed
description Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome criteria (Rome III), which has been validated and the widely used for gastrointestinal disorders. Fifty-one patients with MSA (29 female) were enrolled in the study. Based on the Rome III criteria, constipation was diagnosed in 29 patients (56.9%); irritable bowel syndrome was not detected. Thirty-seven patients (72.5%) were aware of their constipation. The most common constipation symptom was the sensation of anorectal obstruction (68.6%). Patients’ self-awareness of constipation was most strongly correlated to the sensation of incomplete evacuation (odds ratio: 7.377, 95% confidence interval: 1.402–38.817). The number of constipation-related symptoms was correlated with the total levodopa equivalent dose (p < 0.05). Rome criteria, which can detect various constipation symptoms, are useful for evaluating constipation in MSA, and these findings may greatly impact personalized medicine.
format Online
Article
Text
id pubmed-9146870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91468702022-05-29 Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine Mishima, Takayasu Fujioka, Shinsuke Kawazoe, Miki Inoue, Kotoe Arima, Hisatomi Tsuboi, Yoshio J Pers Med Article Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome criteria (Rome III), which has been validated and the widely used for gastrointestinal disorders. Fifty-one patients with MSA (29 female) were enrolled in the study. Based on the Rome III criteria, constipation was diagnosed in 29 patients (56.9%); irritable bowel syndrome was not detected. Thirty-seven patients (72.5%) were aware of their constipation. The most common constipation symptom was the sensation of anorectal obstruction (68.6%). Patients’ self-awareness of constipation was most strongly correlated to the sensation of incomplete evacuation (odds ratio: 7.377, 95% confidence interval: 1.402–38.817). The number of constipation-related symptoms was correlated with the total levodopa equivalent dose (p < 0.05). Rome criteria, which can detect various constipation symptoms, are useful for evaluating constipation in MSA, and these findings may greatly impact personalized medicine. MDPI 2022-05-20 /pmc/articles/PMC9146870/ /pubmed/35629260 http://dx.doi.org/10.3390/jpm12050838 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mishima, Takayasu
Fujioka, Shinsuke
Kawazoe, Miki
Inoue, Kotoe
Arima, Hisatomi
Tsuboi, Yoshio
Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
title Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
title_full Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
title_fullStr Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
title_full_unstemmed Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
title_short Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
title_sort constipation symptoms in multiple system atrophy using rome criteria and their impact on personalized medicine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146870/
https://www.ncbi.nlm.nih.gov/pubmed/35629260
http://dx.doi.org/10.3390/jpm12050838
work_keys_str_mv AT mishimatakayasu constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine
AT fujiokashinsuke constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine
AT kawazoemiki constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine
AT inouekotoe constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine
AT arimahisatomi constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine
AT tsuboiyoshio constipationsymptomsinmultiplesystematrophyusingromecriteriaandtheirimpactonpersonalizedmedicine